home / stock / blfs / blfs quote
Last: | $20 |
---|---|
Change Percent: | 1.25% |
Open: | $19.78 |
Close: | $20 |
High: | $20.13 |
Low: | $19.64 |
Volume: | 190,736 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$20 | $19.78 | $20 | $20.13 | $19.64 | 190,736 | 07-05-2024 |
$20.03 | $20.36 | $20.03 | $20.37 | $19.63 | 166,746 | 07-04-2024 |
$20.03 | $20.36 | $20.03 | $20.37 | $19.63 | 166,746 | 07-03-2024 |
$20.23 | $20.93 | $20.23 | $21.14 | $20.07 | 274,749 | 07-02-2024 |
$20.79 | $21.4 | $20.79 | $21.61 | $20.48 | 213,173 | 07-01-2024 |
$21.43 | $20.61 | $21.43 | $21.57 | $20.44 | 548,701 | 06-28-2024 |
$20.5 | $21.58 | $20.5 | $21.83 | $20.4 | 294,739 | 06-27-2024 |
$21.49 | $21.28 | $21.49 | $21.95 | $21.1 | 306,486 | 06-26-2024 |
$21.36 | $21.43 | $21.36 | $21.665 | $20.9425 | 338,462 | 06-25-2024 |
$21.51 | $21.24 | $21.51 | $21.9 | $20.63 | 543,601 | 06-24-2024 |
$21 | $20.85 | $21 | $21.33 | $20.425 | 656,531 | 06-21-2024 |
$20.83 | $19.83 | $20.83 | $20.9646 | $19.5 | 324,578 | 06-20-2024 |
$19.96 | $20.22 | $19.96 | $20.6339 | $19.63 | 420,126 | 06-19-2024 |
$19.96 | $20.22 | $19.96 | $20.6339 | $19.63 | 420,126 | 06-18-2024 |
$20.25 | $20.49 | $20.25 | $20.94 | $20.08 | 435,563 | 06-17-2024 |
$20.2 | $20.25 | $20.2 | $20.4 | $19.9 | 167,400 | 06-14-2024 |
$20.54 | $21.77 | $20.54 | $22.09 | $20.36 | 199,430 | 06-13-2024 |
$21.77 | $22.38 | $21.77 | $22.67 | $21.66 | 363,171 | 06-12-2024 |
$21.41 | $21.19 | $21.41 | $21.56 | $20.855 | 267,985 | 06-11-2024 |
$21.52 | $19.97 | $21.52 | $21.6 | $19.83 | 412,332 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...